Sensenig Bethany
SEC insider (Form 3/4/5 filer). CIK 0001899935. Director at KalVista Pharmaceuticals, Inc. (KALV) and 2 other issuers. 13 reported Form 4/5 transactions since Sep 2024; latest on Jun 11, 2026. Located in FRAMINGHAM, MA.
Companies Sensenig Bethany has filed insider reports for
- KalVista Pharmaceuticals, Inc. (KALV): Director
- Alpha Cognition Inc. (ACOG): Director
- SUPERNUS PHARMACEUTICALS, INC. (SUPN): Director
Sensenig Bethany
CIK: 0001899935
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Jun 11, 2026KALV
KalVista Pharmaceuticals, Inc.
DispositionDirectStock Option (Right to Buy)
45K shares- - Apr 16, 2026ACOG
Alpha Cognition Inc.
AwardDirect5.5K shares- - Feb 19, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
ExerciseDirect4.5K shares- - Feb 19, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
SaleDirect1.2K shares at avg. $50.31$61K - Feb 19, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
SaleDirect3.3K shares at avg. $51.27$167K - Feb 18, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
AwardDirectDirector Stock Option (Right to Buy)
5K shares- - Feb 18, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
AwardDirectRestricted Stock Unit
3K shares- - Oct 1, 2025KALV
KalVista Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
45K shares- - Aug 14, 2025SUPN
SUPERNUS PHARMACEUTICALS, INC.
SaleDirect5.4K shares at avg. $42.25$227K - Feb 22, 2025SUPN
SUPERNUS PHARMACEUTICALS, INC.
DispositionDirectRestricted Stock Units
5.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 11, 2026 |  KALV KalVista Pharmaceuticals, Inc. | Disposition Stock Option (Right to Buy) | 45,000 | - | - | Direct |
| Apr 16, 2026 |  ACOG Alpha Cognition Inc. | Award | 5,489 | - | $0 | Direct |
| Feb 19, 2026 |  SUPN SUPERNUS PHARMACEUTICALS, INC. | Exercise | 4,475 | - | $0 | Direct |
| Feb 19, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Sale | 1,217 | $50.31 | $61,227 | Direct |
| Feb 19, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Sale | 3,258 | $51.27 | $167,038 | Direct |
| Feb 18, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Award Director Stock Option (Right to Buy) | 4,977 | - | - | Direct |
| Feb 18, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Award Restricted Stock Unit | 2,989 | - | - | Direct |
| Oct 1, 2025 | KALV KalVista Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 45,000 | - | - | Direct |
| Aug 14, 2025 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Sale | 5,369 | $42.25 | $226,840 | Direct |
| Feb 22, 2025 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Disposition Restricted Stock Units | 5,369 | - | - | Direct |
1-10 of 13 transactions